Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...

The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

The two studies — OBERON and TITANIA — evaluated the drug against placebo in adults with symptomatic COPD who had a history of at least two moderate or at least one severe COPD exacerbations (or ...

A doctor shares the story of a young patient with chronic illnesses who chose to stop dialysis and enter hospice.

Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...

Kindeva, a global contract development and manufacturing organization and drug delivery innovator, commemorates its 70 years, since the invention of the pressurized metered dose inhaler (pMDI), a ...

Coal-fired power generation remains a central component of Sri Lanka’s energy mix, with the Lakvijaya (Norochcholai) Power Plant contributing a substantial share of national electricity production.